JPS6118462B2 - - Google Patents
Info
- Publication number
- JPS6118462B2 JPS6118462B2 JP57098610A JP9861082A JPS6118462B2 JP S6118462 B2 JPS6118462 B2 JP S6118462B2 JP 57098610 A JP57098610 A JP 57098610A JP 9861082 A JP9861082 A JP 9861082A JP S6118462 B2 JPS6118462 B2 JP S6118462B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- composition
- bone
- cyanacrylate
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims description 68
- 210000000988 bone and bone Anatomy 0.000 claims description 61
- -1 Ethoxyethyl α-cyanacrylate Chemical compound 0.000 claims description 24
- 230000007547 defect Effects 0.000 claims description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- 159000000007 calcium salts Chemical class 0.000 claims description 10
- 230000008929 regeneration Effects 0.000 claims description 9
- 238000011069 regeneration method Methods 0.000 claims description 9
- 239000004227 calcium gluconate Substances 0.000 claims description 8
- 229960004494 calcium gluconate Drugs 0.000 claims description 8
- 235000013927 calcium gluconate Nutrition 0.000 claims description 8
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical group [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 8
- 239000000945 filler Substances 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- OURRXQUGYQRVML-AREMUKBSSA-N [4-[(2s)-3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl]phenyl]methyl 2,4-dimethylbenzoate Chemical compound CC1=CC(C)=CC=C1C(=O)OCC1=CC=C([C@@H](CN)C(=O)NC=2C=C3C=CN=CC3=CC=2)C=C1 OURRXQUGYQRVML-AREMUKBSSA-N 0.000 claims description 2
- 239000002269 analeptic agent Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000005452 bending Methods 0.000 description 6
- 238000006065 biodegradation reaction Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 206010031252 Osteomyelitis Diseases 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 3
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000021 stimulant Substances 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 206010031256 Osteomyelitis chronic Diseases 0.000 description 2
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 208000005801 spondylosis Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 241000186046 Actinomyces Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000028347 Sinus disease Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000024035 chronic otitis media Diseases 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000001180 ethmoid sinus Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004086 maxillary sinus Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000022949 middle ear disease Diseases 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 208000008798 osteoma Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011470 radical surgery Methods 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57098610A JPS58216050A (ja) | 1982-06-10 | 1982-06-10 | 骨組織欠損の一時的代用組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57098610A JPS58216050A (ja) | 1982-06-10 | 1982-06-10 | 骨組織欠損の一時的代用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58216050A JPS58216050A (ja) | 1983-12-15 |
| JPS6118462B2 true JPS6118462B2 (enrdf_load_stackoverflow) | 1986-05-13 |
Family
ID=14224356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57098610A Granted JPS58216050A (ja) | 1982-06-10 | 1982-06-10 | 骨組織欠損の一時的代用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58216050A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6399163U (enrdf_load_stackoverflow) * | 1987-12-10 | 1988-06-27 | ||
| JPH01189461A (ja) * | 1988-01-25 | 1989-07-28 | Matsushita Electric Ind Co Ltd | 温風暖房器 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6168054A (ja) * | 1984-09-10 | 1986-04-08 | 増原 英一 | 人工骨及び人工歯 |
-
1982
- 1982-06-10 JP JP57098610A patent/JPS58216050A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6399163U (enrdf_load_stackoverflow) * | 1987-12-10 | 1988-06-27 | ||
| JPH01189461A (ja) * | 1988-01-25 | 1989-07-28 | Matsushita Electric Ind Co Ltd | 温風暖房器 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58216050A (ja) | 1983-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6593394B1 (en) | Bioactive and osteoporotic bone cement | |
| US4407793A (en) | Composition for temporary substitution of bone tissue defects | |
| US10052403B2 (en) | Injectable, biodegradable bone cements and methods of making and using same | |
| JP5323354B2 (ja) | 多目的生体材料組成物 | |
| RU2407552C2 (ru) | Инъецируемый композитный материал, пригодный для использования в качестве заменителя костной ткани | |
| CN1307908A (zh) | 无机骨粘合剂及其在人体硬组织修复中的应用 | |
| JP2012192212A (ja) | リン酸カルシウムセメントおよびそれを使用する方法 | |
| JPS62503148A (ja) | 骨セメント | |
| Chen et al. | Brittle and ductile adjustable cement derived from calcium phosphate cement/polyacrylic acid composites | |
| JPS6118462B2 (enrdf_load_stackoverflow) | ||
| CN114917397B (zh) | 一种骨粘合剂的固相组合物及骨粘合剂 | |
| JPH07213598A (ja) | 骨セメント | |
| GB2121067A (en) | Polymerizable composition for temporary substitution of bone tissue defects | |
| RU2508131C2 (ru) | Отверждаемый биокомпозиционный материал для замещения костных дефектов | |
| CA1179944A (en) | Composition for temporary substitution of bone tissue defects | |
| US20250049985A1 (en) | Bone adhesive composition | |
| DE3220932C2 (enrdf_load_stackoverflow) | ||
| JP3423951B2 (ja) | リン酸カルシウム系硬化体用粉剤 | |
| WO2025078066A1 (en) | Bone graft composition based on glucuronic acid-1-phosphate | |
| Bretaña et al. | Calcium silicate-poly (n-butyl-2-cyanoacrylate) nanocomposite for bone tissue adhesion: Paper presented at the “VII International Congress of Biomaterials, BIOMAT'2018”, 14–16 March 2018, Havana, Cuba | |
| CN117919482A (zh) | 一种骨组织植入物粘合剂及其制备方法和应用 | |
| WO2024133597A1 (en) | Bioadhesive composition | |
| TW202423391A (zh) | 骨填補用組合物 | |
| JPH01101976A (ja) | 骨セメント組成物 | |
| JPH11181028A (ja) | 医療用硬化組成物 |